What is Minivelle®?
The world’s smallest estrogen therapy patch to reduce moderate to severe hot flashes and night sweats due to menopause and to help prevent postmenopausal osteoporosis
About the size of a dime, Minivelle® (estradiol transdermal system) provides a discreet route to relief.
Treats moderate to severe hot flashes and night sweats due to menopause.
FDA approved for the prevention of postmenopausal osteoporosis.
Smooth, curved edges may help prevent lifting or snagging associated with everyday wear.
Contains bioidentical estradiol, a plant-based estrogen that is chemically identical to the estrogen made naturally by the body. This does not mean that Minivelle® is safer or more effective than other hormone therapies.
Causes almost no skin irritation and leaves almost no sticky residue behind.
Stays in place even when showering or exercising.
MINIVELLE® (estradiol transdermal system) is a prescription medicine patch that contains estradiol (an estrogen hormone). MINIVELLE is used to reduce moderate to severe hot flashes due to menopause and to help prevent postmenopausal osteoporosis (thin weak bones).
If you use MINIVELLE only to prevent osteoporosis from menopause, talk with your healthcare provider about whether a different treatment or medicine without estrogens might be better for you.
What is the most important information I should know about MINIVELLE (an estrogen hormone)?
MINIVELLE should not be used if you have unusual vaginal bleeding, currently have or have had certain cancers, had a stroke or heart attack, currently have or have had blood clots, currently have or have had liver problems, have been diagnosed with a bleeding disorder, are allergic to MINIVELLE or any of its ingredients, or think you may be pregnant.
Before you take MINIVELLE, tell your healthcare provider if you have unusual vaginal bleeding, have any other medical conditions, are going to have surgery or will be on bed rest, are breast feeding, and about all of the medicines you take.
The most common side effects that may occur with MINIVELLE are headache, breast tenderness, back and limb pain, common cold, upset stomach, nausea, inflammation of the sinuses and irregular vaginal bleeding or spotting.
MINIVELLE should be used at the lowest effective dose and for the shortest duration consistent with your treatment goals and risks.
These are not all the possible side effects of MINIVELLE. Please read the Patient Information section within the full Prescribing Information before taking MINIVELLE. For more information ask your healthcare provider or pharmacist for advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
DOT Matrix™ is a trademark of Noven Pharmaceuticals, Inc.
Minivelle® and the Minivelle Logo are trademarks of Noven Therapeutics, LLC.
Vivelle-Dot® is a registered trademark of Novartis AG.
For information, call 1‑800‑455‑8070.